• Ipsos
  • Insights Hub
  • Insights to Identify & Build Successful Partnerships Between DTx/Biopharma

Insights to Identify & Build Successful Partnerships Between DTx/Biopharma

Revisit our recorded webinar to hear a practical overview of the DTx industry and best practices for DTx and biopharma companies to create the future of patient-centric health together.

The DTx market is rapidly evolving; we see updates on a near-hourly basis on the number and variety of offerings, commercial strategies, partnerships with healthcare players, proof of outcomes and clinical-trial results, FDA approvals, funding rounds, and more. How can DTx and biopharma partner most effectively to create and capture value and build affordable, accessible, and effective patient-centric treatment solutions?

Ipsos hosted a panel of esteemed Digital-Health Influencers and Thought Leaders who joined us to share their deep knowledge and expertise on the state of the market and the best partnering strategies for DTx/digital-care-platform and biopharma companies.

Panelists:

Shwen Gwee, Head of Global Digital Strategy, Bristol Myers Squibb

Melinda Decker, Chief Commercial Officer, Mymee

Owen McCarthy, President and Co-Founder, MedRhythms

Moderator:

Julia Henkels, NA Head of Digital Health, Ipsos Advisory Services

Related news